$8.03
0.02[0.25%]
Last update: 10:36AM Get Real Time Here
Altimmune
(NASDAQ:ALT)Latest News for Altimmune Stock (NASDAQ:ALT)
Altimmune Stock (NASDAQ: ALT)
Categories: All
Friday, May 17, 2024
Tuesday, May 14, 2024
Friday, May 10, 2024
Thursday, May 09, 2024
Tuesday, May 07, 2024
Tuesday, April 30, 2024
Monday, April 29, 2024
- Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Apr 29, 2024, 1:04PM
- Deutsche Bank, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market SessionAvi Kapoor - Apr 29, 2024, 8:31AM
- Altimmune shares are trading lower after Guggenheim downgraded the stock from Buy to Neutral.Benzinga Newsdesk - Apr 29, 2024, 7:15AM
- Guggenheim Downgrades Altimmune to NeutralBenzinga Newsdesk - Apr 29, 2024, 6:41AM
Monday, April 08, 2024
Wednesday, April 03, 2024
Monday, April 01, 2024
Thursday, March 28, 2024
- Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Mar 28, 2024, 2:08PM
- B. Riley Securities Reiterates Buy on Altimmune, Maintains $20 Price TargetBenzinga Newsdesk - Mar 28, 2024, 11:56AM
- REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Mar 28, 2024, 11:00AM
Wednesday, March 27, 2024
- Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?Vandana Singh - Mar 27, 2024, 9:31AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Mar 27, 2024, 9:05AM
- Altimmune shares are trading lower after the company released lean mass preservation data for pemvidutide and worse-than-expected Q4 FY23 earnings.Benzinga Newsdesk - Mar 27, 2024, 7:07AM
- Altimmune Q4 GAAP EPS $(0.54) Misses $(0.43) Estimate, Sales $37.00K Up From $(110.00K) YoYBenzinga Newsdesk - Mar 27, 2024, 7:04AM
- Altimmune Announces Lean Mass Preservation Data For Pemvidutide From Body Composition Study Showing 25.5% Of Weight Loss Derived From Lean Mass And 74.5% Of Weight Loss Was Derived From Adipose TissueBenzinga Newsdesk - Mar 27, 2024, 7:03AM
- Earnings Scheduled For March 27, 2024Benzinga Insights - Mar 27, 2024, 5:02AM
Tuesday, March 26, 2024
Friday, March 22, 2024
Tuesday, March 19, 2024
Monday, March 18, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
- Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Feb 26, 2024, 1:57PM
- Altimmune Stock Surges, Kerrisdale Remains Short: What You Need To KnowAdam Eckert - Feb 26, 2024, 10:22AM
- Kerrisdale Capital Tells Benzinga "We Are Still Short Altimmune (ALT)"Benzinga Newsdesk - Feb 26, 2024, 8:45AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Feb 26, 2024, 8:06AM
Wednesday, February 14, 2024
Tuesday, February 13, 2024
- B. Riley Securities Maintains Buy on Altimmune, Announces $20 Price TargetBenzinga Newsdesk - Feb 13, 2024, 6:04PM
- Watching Altimmune; B Riley Defends Co, Says "Short Report Has Factual Inconsistencies"Benzinga Newsdesk - Feb 13, 2024, 2:41PM
- Altimmune Stock Sinks As Kerrisdale Capital Announces Short Position: 'Obvious Dead End'Adam Eckert - Feb 13, 2024, 2:05PM
- Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Feb 13, 2024, 1:13PM
- Altimmune shares are trading lower after Kerrisdale Capital issued a short report on the stock.Benzinga Newsdesk - Feb 13, 2024, 11:17AM
- Jim Cramer Calls Affirm 'A Winner,' But Not C3.ai: 'I Can't Recommend A Stock With No Earnings'Avi Kapoor - Feb 13, 2024, 9:55AM
- Watching Altimmune; Kerrisdale Capital Issues Report On Co Titled "Altimmune, Inc. (ALT) Fat Chance"Benzinga Newsdesk - Feb 13, 2024, 9:42AM